Skip to main content
Veterinary Medicines

Zantoral 30mg/ml oral solution for dogs

Authorised
  • Ranitidine

Product identification

Medicine name:
Zantoral 30mg/ml oral solution for dogs
Active substance:
  • Ranitidine
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Ranitidine
    30.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA02BA02
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • High density polyethylene bottle 48 ml with high density polyethylene stoppers and a low density polyethylene plug. 3 ml polypropylene/silicone syringe, graduated every 0.1 ml to 3 ml.
  • High density polyethylene bottle 24 ml with high density polyethylene stoppers and a low density polyethylene plug. 3 ml polypropylene/silicone syringe, graduated every 0.1 ml to 3 ml.
  • High density polyethylene bottle 12 ml with high density polyethylene stoppers and a low density polyethylene plug. 3 ml polypropylene/silicone syringe, graduated every 0.1 ml to 3 ml.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Emdoka
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 105328
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0141/001
Concerned member states:
  • Austria
  • Belgium
  • Germany
  • Luxembourg
  • Netherlands

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 10/10/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."